NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 5 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $47,000 | -44.0% | 18,912 | -18.2% | 0.01% | +60.0% |
| Q1 2017 | $84,000 | -9.7% | 23,107 | -34.0% | 0.01% | -16.7% |
| Q4 2016 | $93,000 | -7.9% | 35,007 | +13.3% | 0.01% | +20.0% |
| Q3 2016 | $101,000 | +14.8% | 30,907 | +17.5% | 0.01% | 0.0% |
| Q2 2016 | $88,000 | -62.1% | 26,307 | -72.3% | 0.01% | -66.7% |
| Q1 2016 | $232,000 | – | 94,894 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARATHON CAPITAL MANAGEMENT | 55,000 | $179,000 | 0.09% |
| WEDBUSH SECURITIES INC | 180,945 | $590,000 | 0.09% |
| Brown Advisory Securities, LLC | 28,000 | $91,000 | 0.03% |
| FNY Managed Accounts LLC | 8,000 | $26,080,000 | 0.02% |
| FT Options LLC | 10,000 | $26,000 | 0.02% |
| WEBSTER BANK, N. A. | 40,000 | $130,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 30,907 | $101,000 | 0.01% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $82,000 | 0.00% |
| NATIONAL PLANNING CORP | 11,000 | $32,000 | 0.00% |
| Virtu KCG Holdings LLC | 24,705 | $81,000 | 0.00% |